Filter

Refine by date

—

Refine by collections

  • Print
  • Save

Search Results

You are looking at 1 - 10 of 216 items for :

  • radioiodine x
Clear All
Furio Pacini Section of Endocrinology, University of Siena, Siena, Italy

Search for other papers by Furio Pacini in
Google Scholar
PubMed Close
,
Dagmar Fuhrer Department of Endocrinology, Diabetes and Metabolism, West German Cancer Centre (WTZ), University Hospital Essen, University Duisburg-Essen, Essen, Germany

Search for other papers by Dagmar Fuhrer in
Google Scholar
PubMed Close
,
Rossella Elisei Section of Endocrinology, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy

Search for other papers by Rossella Elisei in
Google Scholar
PubMed Close
,
Daria Handkiewicz-Junak Department of Nuclear Medicine and Endocrine Oncology, Maria Skłodowska-Curie National Research Institute of Oncology, Gliwice Branch, Gliwice, Poland

Search for other papers by Daria Handkiewicz-Junak in
Google Scholar
PubMed Close
,
Sophie Leboulleux Gustave Roussy Cancer Campus and University Paris-Saclay, Villejuif, Cedex, France

Search for other papers by Sophie Leboulleux in
Google Scholar
PubMed Close
,
Markus Luster Department of Nuclear Medicine, University Hospital Marburg, Marburg, Germany

Search for other papers by Markus Luster in
Google Scholar
PubMed Close
,
Martin Schlumberger Gustave Roussy Cancer Campus and University Paris-Saclay, Villejuif, Cedex, France

Search for other papers by Martin Schlumberger in
Google Scholar
PubMed Close
, and
Johannes W Smit Radboud University Medical Center, Nijmegen, Netherlands

Search for other papers by Johannes W Smit in
Google Scholar
PubMed Close

-off (e.g. >2 ng/mL) should lead to selection for RAI. Whenever risk factors and patients’ selection for total thyroidectomy and radioiodine are evaluated, wide differences between countries as environmental factors, preclinical care and healthcare

Article Type:
Other
Collections:
Thyroid cancer - clinical
DOI:
https://doi.org/10.1530/ETJ-21-0046
Volume/Issue:
Volume 11: Issue 1
Open access
Ian D Hay Department of Medicine 1, Mayo Clinic College of Medicine and Science, Rochester, Minnesota, USA

Search for other papers by Ian D Hay in
Google Scholar
PubMed Close
,
Suneetha Kaggal Department of Health Sciences Research, Mayo Clinic College of Medicine and Science, Rochester, Minnesota, USA

Search for other papers by Suneetha Kaggal in
Google Scholar
PubMed Close
, and
Geoffrey B Thompson Department of Surgery, Mayo Clinic College of Medicine and Science, Rochester, Minnesota, USA

Search for other papers by Geoffrey B Thompson in
Google Scholar
PubMed Close

are convinced that at our institution, radioiodine remnant ablation (RRA), when administered after potentially curative bilateral thyroidectomy (BT) to low-risk (MACIS scores <6) adult PTC (APTC) patients, has not reduced ( 7 ) either cause

Article Type:
Research Article
Collections:
Thyroid cancer - clinical
DOI:
https://doi.org/10.1530/ETJ-22-0084
Volume/Issue:
Volume 11: Issue 4
Open access
Carla Gambale Department of Clinical and Experimental Medicine, Unit of Endocrinology, University Hospital of Pisa, Pisa, Italy

Search for other papers by Carla Gambale in
Google Scholar
PubMed Close
,
Alessandro Prete Department of Clinical and Experimental Medicine, Unit of Endocrinology, University Hospital of Pisa, Pisa, Italy

Search for other papers by Alessandro Prete in
Google Scholar
PubMed Close
,
Lea Contartese Department of Clinical and Experimental Medicine, Unit of Endocrinology, University Hospital of Pisa, Pisa, Italy

Search for other papers by Lea Contartese in
Google Scholar
PubMed Close
,
Liborio Torregrossa Department of Surgical, Medical, Molecular Pathology and Critical Area, Anatomic Pathology Section, University Hospital of Pisa, Pisa, Italy

Search for other papers by Liborio Torregrossa in
Google Scholar
PubMed Close
,
Francesca Bianchi Department of Nuclear Medicine, University Hospital of Pisa, Pisa, Italy

Search for other papers by Francesca Bianchi in
Google Scholar
PubMed Close
,
Eleonora Molinaro Department of Clinical and Experimental Medicine, Unit of Endocrinology, University Hospital of Pisa, Pisa, Italy

Search for other papers by Eleonora Molinaro in
Google Scholar
PubMed Close
,
Gabriele Materazzi Department of Surgical, Medical, Molecular Pathology and Critical Area, Unit of Endocrine Surgery, University Hospital of Pisa, Pisa, Italy

Search for other papers by Gabriele Materazzi in
Google Scholar
PubMed Close
,
Rossella Elisei Department of Clinical and Experimental Medicine, Unit of Endocrinology, University Hospital of Pisa, Pisa, Italy

Search for other papers by Rossella Elisei in
Google Scholar
PubMed Close
, and
Antonio Matrone Department of Clinical and Experimental Medicine, Unit of Endocrinology, University Hospital of Pisa, Pisa, Italy

Search for other papers by Antonio Matrone in
Google Scholar
PubMed Close

-Tg) ≥10 ng/mL or rising thyroglobulin antibodies (TgAb) levels with negative imaging; InR were defined by LT4-Tg <1 ng/mL or rhTSH-Tg <10 ng/mL or stable/declining TgAb levels with non-specific findings on imaging or faint radioiodine uptake in thyroid bed

Article Type:
Research Article
Collections:
Thyroid cancer - clinical
DOI:
https://doi.org/10.1530/ETJ-23-0052
Volume/Issue:
Volume 12: Issue 6
Open access
Ola Lindgren Department of Endocrinology, Lund University, Malmö, Sweden
Department of Clinical Sciences, Skåne University Hospital, Malmö, Sweden

Search for other papers by Ola Lindgren in
Google Scholar
PubMed Close
,
Pernilla Asp Department of Oncology, Skåne University Hospital, Lund, Sweden

Search for other papers by Pernilla Asp in
Google Scholar
PubMed Close
,
Anna Sundlöv Department of Oncology, Lund University, and Department of Clinical Sciences, Skåne University Hospital, Lund, Sweden

Search for other papers by Anna Sundlöv in
Google Scholar
PubMed Close
,
Jan Tennvall Department of Oncology, Lund University, and Department of Clinical Sciences, Skåne University Hospital, Lund, Sweden

Search for other papers by Jan Tennvall in
Google Scholar
PubMed Close
,
Bushra Shahida Department of Clinical Sciences Malmö, and Diabetes and Endocrinology, Lund University, Malmö, Sweden

Search for other papers by Bushra Shahida in
Google Scholar
PubMed Close
,
Tereza Planck Department of Endocrinology, Lund University, Malmö, Sweden
Department of Clinical Sciences, Skåne University Hospital, Malmö, Sweden

Search for other papers by Tereza Planck in
Google Scholar
PubMed Close
,
Peter Åsman Department of Clinical Sciences Malmö, Ophthalmology, Lund University, and Department of Ophthalmology, Skåne University Hospital, Malmö, Sweden

Search for other papers by Peter Åsman in
Google Scholar
PubMed Close
, and
Mikael Lantz Department of Endocrinology, Lund University, Malmö, Sweden
Department of Clinical Sciences, Skåne University Hospital, Malmö, Sweden

Search for other papers by Mikael Lantz in
Google Scholar
PubMed Close

increases the risk of GD approximately twofold and GO approximately threefold [ 6 ]. Independently of smoking, it has also been shown that higher TRAb increase the risk of GO both at and after diagnosis of GD [ 7 , 8 ]. Treatment of GD with radioiodine is

Article Type:
Research Article
DOI:
https://doi.org/10.1159/000495504
Volume/Issue:
Volume 8: Issue 2
Free access
Rosa M. García-Moreno Endocrinology and Nutrition Department, Hospital Universitario La Paz, Madrid, Spain

Search for other papers by Rosa M. García-Moreno in
Google Scholar
PubMed Close
,
Cristina Escabias Nuclear Medicine Department, Hospital Universitario La Paz, Madrid, Spain

Search for other papers by Cristina Escabias in
Google Scholar
PubMed Close
,
Cristina Utrilla Radiology Department, Hospital Universitario La Paz, Madrid, Spain

Search for other papers by Cristina Utrilla in
Google Scholar
PubMed Close
,
Elena Ruiz-Bravo Pathology Department, Hospital Universitario La Paz, Madrid, Spain

Search for other papers by Elena Ruiz-Bravo in
Google Scholar
PubMed Close
,
Margarita Sánchez Ophthalmology Department, Hospital Universitario La Paz, Madrid, Spain

Search for other papers by Margarita Sánchez in
Google Scholar
PubMed Close
, and
Beatriz Lecumberri Endocrinology and Nutrition Department, Hospital Universitario La Paz, Madrid, Spain

Search for other papers by Beatriz Lecumberri in
Google Scholar
PubMed Close

Established Facts Orbital radioiodine uptake is highly uncommon, and some conditions associated with this finding are metastases as well as false-positive results due to contamination, inflammation, etc. Cystic structures located in

Article Type:
Case Report
DOI:
https://doi.org/10.1159/000499911
Volume/Issue:
Volume 8: Issue 4
Free access
Ana Piñar-Gutiérrez UGC Endocrinología y Nutrición, Hospital Universitario Virgen del Rocío, Sevilla, España

Search for other papers by Ana Piñar-Gutiérrez in
Google Scholar
PubMed Close
,
Ana R Romero-Lluch UGC Endocrinología y Nutrición, Hospital Universitario Virgen del Rocío, Sevilla, España

Search for other papers by Ana R Romero-Lluch in
Google Scholar
PubMed Close
,
Suset Dueñas-Disotuar UGC Endocrinología y Nutrición, Hospital Universitario Virgen del Rocío, Sevilla, España

Search for other papers by Suset Dueñas-Disotuar in
Google Scholar
PubMed Close
,
Irene de Lara-Rodríguez UGC Endocrinología y Nutrición, Hospital Universitario Virgen del Rocío, Sevilla, España

Search for other papers by Irene de Lara-Rodríguez in
Google Scholar
PubMed Close
,
María Ángeles Gálvez-Moreno Servicio de Endocrinología, Hospital Universitario Reina Sofía, Córdoba, España

Search for other papers by María Ángeles Gálvez-Moreno in
Google Scholar
PubMed Close
,
Tomás Martín-Hernández Servicio de Endocrinología, Hospital Universitario Virgen Macarena, Sevilla, España

Search for other papers by Tomás Martín-Hernández in
Google Scholar
PubMed Close
,
Jorge García-Alemán Servicio de Endocrinología, Hospital Universitario Virgen de la Victoria, Málaga, España

Search for other papers by Jorge García-Alemán in
Google Scholar
PubMed Close
,
Guillermo Martínez-de Pinillos Servicio de Endocrinología, Hospital Universitario Virgen de Valme, Sevilla, España

Search for other papers by Guillermo Martínez-de Pinillos in
Google Scholar
PubMed Close
, and
Elena Navarro-González UGC Endocrinología y Nutrición, Hospital Universitario Virgen del Rocío, Sevilla, España

Search for other papers by Elena Navarro-González in
Google Scholar
PubMed Close

tyrosine kinase inhibitors (TKIs). However, in up to 50% of cases, BMs have the absence of radioiodine uptake ( 11 ), and data on the effectiveness of TKIs are limited in this clinical entity ( 12 ). In parallel to these treatments, the role of

Article Type:
Research Article
Collections:
Thyroid cancer - clinical
DOI:
https://doi.org/10.1530/ETJ-23-0086
Volume/Issue:
Volume 12: Issue 5
Open access
Fahim U. Hassan Nuclear Medicine Department, Borough Wing, Guy's Hospital, London, UK

Search for other papers by Fahim U. Hassan in
Google Scholar
PubMed Close
and
Hosahalli K. Mohan Nuclear Medicine Department, Borough Wing, Guy's Hospital, London, UK

Search for other papers by Hosahalli K. Mohan in
Google Scholar
PubMed Close

, age, tumour size, histological subtypes, extrathyroidal spread, metastatic disease and iodine avidity [ 5 ]. Surgery, which includes total thyroidectomy and lymph node dissection followed by radioiodine ablation, remains the mainstay of treatment for

Article Type:
Research Article
DOI:
https://doi.org/10.1159/000435836
Volume/Issue:
Volume 4: Issue 4
Free access
E.N. Klein Hesselink Department of Endocrinology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands

Search for other papers by E.N. Klein Hesselink in
Google Scholar
PubMed Close
and
T.P. Links Department of Endocrinology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands

Search for other papers by T.P. Links in
Google Scholar
PubMed Close

, standardized treatment has consisted of a total thyroidectomy accompanied by a central or lateral neck lymph node dissection if indicated, followed by radioiodine ( 131 I) ablation, and thyroid hormone suppression therapy (THST) during follow-up. Although

Article Type:
Review Article
DOI:
https://doi.org/10.1159/000432397
Volume/Issue:
Volume 4: Issue 2
Free access
Abdul Rehman Syed University of Calgary, Calgary, Alberta, Canada

Search for other papers by Abdul Rehman Syed in
Google Scholar
PubMed Close
,
Aakash Gorana Arnie Charbonneau Cancer Institute, Cumming School of Medicine, University of Calgary, Alberta, Canada

Search for other papers by Aakash Gorana in
Google Scholar
PubMed Close
,
Erik Nohr Alberta Precision Laboratories, Molecular Pathology Program, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada

Search for other papers by Erik Nohr in
Google Scholar
PubMed Close
,
Xiaoli-Kat Yuan Precision Oncology Hub Laboratory, Tom Baker Cancer Centre, Calgary, Alberta, Canada

Search for other papers by Xiaoli-Kat Yuan in
Google Scholar
PubMed Close
,
Parthiv Amin MASc Department of Radiology, Cumming School of Medicine, University of Calgary, Calgary Alberta, Canada

Search for other papers by Parthiv Amin MASc in
Google Scholar
PubMed Close
,
Sana Ghaznavi Arnie Charbonneau Cancer Institute, Department of Medicine, Section of Endocrinology, University of Calgary, Calgary, Alberta, Canada

Search for other papers by Sana Ghaznavi in
Google Scholar
PubMed Close
,
Debbie Lamb Arnie Charbonneau Cancer Institute, Cumming School of Medicine, University of Calgary, Alberta, Canada

Search for other papers by Debbie Lamb in
Google Scholar
PubMed Close
,
John McIntyre Precision Oncology Hub Laboratory, Tom Baker Cancer Centre, Calgary, Alberta, Canada

Search for other papers by John McIntyre in
Google Scholar
PubMed Close
,
Markus Eszlinger Department of Oncology, Cumming School of Medicine, and Arnie Charbonneau Cancer Institute, University of Calgary, Calgary, Alberta, Canada

Search for other papers by Markus Eszlinger in
Google Scholar
PubMed Close
, and
Ralf Paschke Departments of Medicine, Section of Endocrinology, Oncology, Pathology and Laboratory Medicine, Biochemistry and Molecular Biology and Arnie Charbonneau Cancer Institute, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada

Search for other papers by Ralf Paschke in
Google Scholar
PubMed Close

treatment ( 1 ). Two-thirds of metastatic DTCs lose their ability to uptake radioiodine (RAI) due to oncogene driver mutations silencing thyroid iodide-metabolizing genes, causing them to be RAI-resistant or refractory ( 1 , 2 , 3 ). Patients with RAI

Article Type:
Research Article
Collections:
Thyroid cancer - basic and translational
DOI:
https://doi.org/10.1530/ETJ-23-0227
Volume/Issue:
Volume 13: Issue 3
Open access
Nicholas S. Andresen Department of Radiation Oncology, University of Iowa, Iowa City, Iowa, USA

Search for other papers by Nicholas S. Andresen in
Google Scholar
PubMed Close
,
John M. Buatti Department of Radiation Oncology, University of Iowa, Iowa City, Iowa, USA

Search for other papers by John M. Buatti in
Google Scholar
PubMed Close
,
Hamed H. Tewfik Iowa City Cancer Treatment Center, Iowa City, Iowa, USA

Search for other papers by Hamed H. Tewfik in
Google Scholar
PubMed Close
,
Nitin A. Pagedar Department of Otolaryngology-Head and Neck Surgery, University of Iowa, Iowa City, Iowa, USA

Search for other papers by Nitin A. Pagedar in
Google Scholar
PubMed Close
,
Carryn M. Anderson Department of Radiation Oncology, University of Iowa, Iowa City, Iowa, USA

Search for other papers by Carryn M. Anderson in
Google Scholar
PubMed Close
, and
John M. Watkins Department of Radiation Oncology, University of Iowa, Iowa City, Iowa, USA

Search for other papers by John M. Watkins in
Google Scholar
PubMed Close

with postoperative radioiodine therapy (RAI) to ablate residual thyroid tissue and, in intermediate- to high-risk cases, to postoperatively (adjuvantly) treat occult foci of cancer in the surgical bed and elsewhere (for the purposes of this review, we

Article Type:
Review Article
DOI:
https://doi.org/10.1159/000468927
Volume/Issue:
Volume 6: Issue 4
Free access